Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monocytic THP-1 cells diverge significantly from their primary counterparts: a comparative examination of the chromosomal conformations and transcriptomes. | Hereditas | 2021 | 34740370 | PubTator, text mining | PubMed |
| Implications of cell division cycle associated 4 on the Wilm's tumor cells viability via AKT/mTOR signaling pathway. | Ren Fail | 2021 | 34723730 | PubTator, text mining | PubMed |
| Timely termination of repair DNA synthesis by ATAD5 is important in oxidative DNA damage-induced single-strand break repair. | Nucleic Acids Res | 2021 | 34718749 | PubTator, text mining | PubMed |
| Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance. | Genes (Basel) | 2021 | 34680945 | PubTator, text mining | PubMed |
| Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma. | Biomedicines | 2021 | 34680590 | PubTator, text mining | PubMed |
| The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. | Drug Des Devel Ther | 2021 | 34675489 | PubTator, text mining | PubMed |
| Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer. | Genome Med | 2021 | 34663432 | PubTator, text mining | PubMed |
| Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma. | Med Oncol | 2021 | 34655361 | PubTator, text mining | PubMed |
| Regulation of Long Non-coding RNA KCNQ1OT1 Network in Colorectal Cancer Immunity. | Front Genet | 2021 | 34630508 | PubTator, text mining | PubMed |
| DDK/Hsk1 phosphorylates and targets fission yeast histone deacetylase Hst4 for degradation to stabilize stalled DNA replication forks. | Elife | 2021 | 34608864 | PubTator, text mining | PubMed |
| Combination therapy for HCC: from CRISPR screening to the design of clinical therapies. | Signal Transduct Target Ther | 2021 | 34608130 | PubTator, text mining | PubMed |
| Discovery of AS-0141, a Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid Cancers. | J Med Chem | 2021 | 34607435 | PubTator, text mining | PubMed |
| Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance. | FEBS Open Bio | 2021 | 34586751 | PubTator, text mining | PubMed |
| Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in Colorectal Cancer. | Medicina (Kaunas) | 2021 | 34577783 | PubTator, text mining | PubMed |
| Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective. | Cancers (Basel) | 2021 | 34572959 | PubTator, text mining | PubMed |
| Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application. | Nat Nanotechnol | 2021 | 34556833 | PubTator, text mining | PubMed |
| Mapping the landscape of synthetic lethal interactions in liver cancer. | Theranostics | 2021 | 34522226 | PubTator, text mining | PubMed |
| Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility. | Nat Commun | 2021 | 34518541 | PubTator, text mining | PubMed |
| REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. | Mol Cell | 2021 | 34508659 | PubTator, text mining | PubMed |
| Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy. | Stem Cell Res Ther | 2021 | 34503562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=21